Invasive squamous cell carcinoma of the eyes in patients with epidermodysplasia verruciformis.

KE Sharquie, SA Al-Meshhadani… - Saudi medical …, 2007 - europepmc.org
We described 3 male patients with epidermodysplasia verruciformis seen in the Department
of Dermatology and Venereology, Baghdad Teaching Hospital; their ages were 25, 30 and …

Acral lentiginous melanoma versus lentigo maligna melanoma among Iraqi patients.

KE Sharquie, SA Al-Meshhadani… - Saudi medical …, 2007 - europepmc.org
Objective To report the different clinical aspects of malignant melanoma and their varieties
in Iraqi patients. Methods We carried out this study in the Department of Dermatology and …

[PDF][PDF] Therapeutic Evaluation of Spironolactone and Finasteride in the Treatment of Acne Vulgaris

KE Sharquie, SA Al-Meshhadani, AA Al-Nuaimy… - Iraqi Postgraduate …, 2007 - iasj.net
BACKGROUND: Antiandrogens have been developed to treat acne; spironolactone, an
androgen receptor blocker, and finasteride, 5 alpha reductase inhibitor, are two …

Therapeutic evaluation of spironolactone and finasteride in the treatment of acne vulgaris

S Khalifa E, AM Sabeeh A, AN Adil A, AW Ghassan H - 2007 - pesquisa.bvsalud.org
Antiandrogens have been developed to treat acne; spironolactone, an androgen receptor
blocker, and fmasteride, 5 alpha reductase inhibitor, are two antiandrogens that can be used …

Acral lentiginous melanoma versus lentigo maligna melanoma among Iraqi patients

S Khalifa E, AM Sabeeh A, AN Adil A - 2007 - pesquisa.bvsalud.org
To report the different clinical aspects of malignant melanoma and their varieties in Iraqi
patients. We carried out this study in the Department of Dermatology and Venereology, Baghdad …

Invasive squamous cell carcinoma of the eyes in patients with epidermodysplasia verruciformis

S Khalifa E, AM Sabeeh A, AN Adil A - 2007 - pesquisa.bvsalud.org
We described 3 male patients with epidermodysplasia verruciformis seen in the Department
of Dermatology and Venereology, Baghdad Teaching Hospital; their ages were 25, 30 and …